Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Capital Employed (2016 - 2026)

United Therapeutics' Return on Capital Employed history spans 16 years, with the latest figure at 21.16% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 1.0% to 21.16% in Q4 2025 year-over-year; TTM through Dec 2025 was 21.16%, a 1.0% decrease, with the full-year FY2025 number at 21.14%, up 4.0% from a year prior.
  • Return on Capital Employed hit 21.16% in Q4 2025 for United Therapeutics, roughly flat from 21.08% in the prior quarter.
  • Over the last five years, Return on Capital Employed for UTHR hit a ceiling of 21.87% in Q2 2024 and a floor of 8.37% in Q1 2021.
  • Historically, Return on Capital Employed has averaged 17.51% across 5 years, with a median of 18.25% in 2022.
  • Biggest five-year swings in Return on Capital Employed: crashed -851bps in 2021 and later surged 991bps in 2022.
  • Tracing UTHR's Return on Capital Employed over 5 years: stood at 11.57% in 2021, then soared by 52bps to 17.59% in 2022, then rose by 7bps to 18.84% in 2023, then increased by 12bps to 21.17% in 2024, then decreased by 0bps to 21.16% in 2025.
  • Business Quant data shows Return on Capital Employed for UTHR at 21.16% in Q4 2025, 21.08% in Q3 2025, and 19.84% in Q2 2025.